Randomized clinical trials in oncology commentary.
In this article the author addresses the major questions and problems that arrise while analyzing randomized clinical trials. A brief description is given of three problems, which are how to bring the derived information into broad applicability, when are the results of a trial significant enough to make it a standard for care and the issue of quality control.
Brennan
Murray F
MF
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. brennanm@mskcc.org
D019317:Evidence-Based Medicine; D006801:Humans; D008495:Medical Oncology / Q000592:standards; D016032:Randomized Controlled Trials as Topic / Q000592:standards